Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erik Hack

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Molecular Immunology|June 12, 2010
Serine proteases of the human immune system in health and diseaseKirstin M Heutinck, Ineke J M ten Berge, C Erik Hack, et al.
Arthritis and Rheumatism|March 31, 2006
Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation productsDiana Wouters, Alexandre E Voskuyl, Esmeralda T H Molenaar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding proteinAndreas P Sjöberg, Leendert A Trouw, Fabian D G McGrath, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Effect of reactive site loop elongation on the inhibitory activity of C1-inhibitorIneke G A Bos, Yvonne T P Lubbers, Eric Eldering, et al.
Intensive Care Medicine|July 13, 2005
Elastase and granzymes during meningococcal disease in children: correlation to disease severityJob B M van Woensel, Maarten H Biezeveld, C Erik Hack, et al.
Journal of Immunological Methods|April 26, 2005
Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activationDiana Wouters, Hans D Wiessenberg, Margreet Hart, et al.
Clinical and Translational Allergy|July 25, 2019
High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedemaZonne L M Hofman, Nikki van West, C Erik Hack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIbEdwin van Mirre, Jessica L Teeling, Jos W M van der Meer, et al.
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction?Paul A J Krijnen, Christof Meischl, Remco Nijmeijer, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Administration of C1 inhibitor reduces neutrophil activation in patients with sepsisSacha Zeerleder, Christoph Caliezi, Gerard van Mierlo, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Molecular Immunology|June 12, 2010
Serine proteases of the human immune system in health and diseaseKirstin M Heutinck, Ineke J M ten Berge, C Erik Hack, et al.
Arthritis and Rheumatism|March 31, 2006
Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation productsDiana Wouters, Alexandre E Voskuyl, Esmeralda T H Molenaar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding proteinAndreas P Sjöberg, Leendert A Trouw, Fabian D G McGrath, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Effect of reactive site loop elongation on the inhibitory activity of C1-inhibitorIneke G A Bos, Yvonne T P Lubbers, Eric Eldering, et al.
Intensive Care Medicine|July 13, 2005
Elastase and granzymes during meningococcal disease in children: correlation to disease severityJob B M van Woensel, Maarten H Biezeveld, C Erik Hack, et al.
Journal of Immunological Methods|April 26, 2005
Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activationDiana Wouters, Hans D Wiessenberg, Margreet Hart, et al.
Clinical and Translational Allergy|July 25, 2019
High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedemaZonne L M Hofman, Nikki van West, C Erik Hack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIbEdwin van Mirre, Jessica L Teeling, Jos W M van der Meer, et al.
Cardiovascular & Hematological Disorders Drug Targets|June 22, 2006
Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction?Paul A J Krijnen, Christof Meischl, Remco Nijmeijer, et al.
Clinical and Diagnostic Laboratory Immunology|July 11, 2003
Administration of C1 inhibitor reduces neutrophil activation in patients with sepsisSacha Zeerleder, Christoph Caliezi, Gerard van Mierlo, et al.
Pageof 17